CMS Annual Report on National Health Spending

The Centers for Medicare and Medicaid (CMS) released its annual report on national health spending. According to the CMS press release, 2008 had the "the slowest rate of growth since [CMS] started officially tracking expenditures in 1960." The rate slowed to 4.4 percent down from 6.0 percent in 2007.

However, despite the decelerated growth, health spending's share of the gross domestic product increased from 15.9 percent in 2007 to 16.2 percent in 2008.

CMS also reports the following statistics:

  • Hospital spending in 2008 grew 4.5 percent to $718.4 billion, compared to 5.9 percent in 2007, the slowest rate of increase since 1998. 
  • Physician and clinical services’ spending increased 5.0 percent in 2008, a deceleration from 5.8 percent in 2007. 
  • Retail prescription drug spending growth also decelerated to 3.2 percent in 2008 as per capita use of prescription medications declined slightly, mainly due to impacts of the recession, a low number of new product introductions, and safety and efficacy concerns.
  • Spending growth for both nursing home and home health services decelerated in 2008.   For nursing homes, spending grew 4.6 percent in 2008 compared to 5.8 percent in 2007. 
  • Total health care spending by public programs, such as Medicare and Medicaid, grew 6.5 percent in 2008, the same rate as in 2007. 
  • Health care spending by private sources of funds grew only 2.6 percent in 2008 compared to 5.6 percent in 2007. 
  • Private health insurance premiums grew 3.1 percent in 2008, a deceleration from 4.4 percent in 2007.

Gainsharing Programs Continue to Receive Favorable Reviews from OIG

Extending its string of positive advisory opinions involving gainsharing arrangements, over the past few months the OIG has issued three new, favorable gainsharing opinions. While the three gainsharing arrangements reviewed by the OIG in the recent opinions bear striking similarities to gainsharing arrangements that received favorable treatment in the past, there are some differences that suggest a broadening of the type of gainsharing arrangements that will receive OIG approval.

For instance, OIG Advisory Opinion 08-09 involves the first gainsharing arrangement that did not involve a hospital cardiology program. Rather, this opinion involved sharing savings from waste and cost reduction measures in certain surgical procedures with orthopedic surgeons and neurosurgeons. 

OIG Advisory Opinion 08-15 addresses a gainsharing arrangement involving cardiologists that has a term of three years. Previously, all gainsharing arrangements approved by the OIG were limited to one-year deals. By structuring the annual payments in a manner that ensured the participating cardiologists were not compensated twice for achieving duplicate savings, the OIG was receptive to approving a multi-year arrangement. This development is significant because a considerable downside to gainsharing arrangements had been the perceived one-year limitation. The 3 year term here is consistent with the maximum term proposed by CMS in the proposed Stark Law gainsharing exception.

Finally, OIG Advisory Opinion 08-16 is the first gainsharing arrangement to involve a commercial insurer and corresponding pay-for-performance initiatives. The hospital and commercial insurer developed a pay-for-performance program under which the insurer pays the hospital bonus compensation if the hospital meets specified quality and effeciency standards. The hospital entered into an agreement with a group of physicians to assist in meeting those standards and, if met, the hospital shares a portion of the bonus compensation from the insurer with the physicians. The program analyzed in this opinion represents an expansion of the type of quality-promoting arrangements the OIG is willing to accept.

Despite their unique characteristics, the arrangements in these opinions still incorporated key safeguards the OIG views as critical to protecting against potential fraud and abuse. Such safeguards include:

§            Transparency. The specific cost-saving actions and resulting savings are clearly and separately identified. The hospitals and participating physicians disclose the arrangement to patients.

§           No Adverse Impact on Patient Care. The parties provided credible medical support for the position that implementation of the cost-saving recommendations does not adversely affect patient care.

§           No Disproportionate Impact on Medicare Patients or Medicare Program. Amounts paid under the arrangement are based on all procedures regardless of a patient's insurance coverage and a disproportionate amount of such procedures are not performed on Medicare patients. If a participating physician's volume of procedures performed on Medicare patients in the current year exceeds the volume of like procedures performed on Medicare patients in the base year, there is no sharing of cost savings for the additional procedures.

§           Protections Against Inappropriate Reductions in Services. The arrangement utilizes objective historical and clinical measures to establish baseline thresholds beyond which no savings accrue to the participating physicians.  

§           Product Standardization Without Limiting Selection. Participating physicians still have available the same selection of devices and supplies after implementation of the arrangement as before. The arrangement is designed to produce savings through inherent clinical and fiscal value, not from restricting the availability of devices and supplies.

§           Compensation Cap and Per Capita Distribution. A cap on total compensation to the participating physicians is established based on projected cost savings and the compensation is distributed by the participating physician groups to their members on a per capita basis.

§           Participation Limited to Physicians on Staff. Participation in the arrangement is limited to physicians already on the hospitals' medical staffs. Also, the arrangement is limited to specific specialties (i.e. cardiology, orthopedics), so no surgeons or other physicians who refer patients to the participating physician groups can be rewarded through the arrangement.

§           Minimizing Incentive to Steer Costly Patients to Other Hospitals. Case severity, ages and payors of the patient population treated under the arrangement are monitored by a committee of hospital personnel and participating physicians. If significant changes from historical measures indicate a physician has altered his/her referral patterns to steer sicker, costlier patients away from the hospital, the physician can be terminated from the arrangement.

When structured appropriately to limit risk under the Anti-Kickback Statute and the Civil Monetary Penalties Law, the OIG has continually recognized the positive attributes of gainsharing programs. Gainsharing continues to be an evolving area with regard to fraud and abuse law and further developments are anticipated. CMS has issued requests for comments on several questions related to its proposed gainsharing exception to the Stark Law and it will be interesting to see how those questions and comments influence the development of the proposed exception.

Resource Allocation and Health Care Enforcement

The OIG recently released a report that was critical of the oversight and enforcement by CMS with respect to the HIPAA Security Rule. The report included the following remarks: “CMS had taken limited actions to ensure that covered entities adequately implement the HIPAA Security Rule. These actions had not provided effective oversight or encouraged enforcement of the HIPAA Security Rule by covered entities.” The report notes that CMS primarily relied on complaints to identify non-compliant covered entities that it might investigate and recommends that CMS establish policies and procedures for conducting HIPAA Security Rule compliance reviews of covered entities.

The report raises an interesting topic that should receive more scrutiny in upcoming years: Resource allocation for enforcement of Federal health care laws and regulations. OIG indicates that CMS could be more effective in its oversight and enforcement of the HIPAA Security Rule by conducting compliance reviews. But, this begs the question: Why did CMS not conduct compliance reviews during the period under review?

If the answer is that CMS allocated significant resources to compliance reviews and simply failed to execute, then a critique on this failure may be justified. But, if CMS chose not to engage in compliance reviews during the period under review, relying on other (perhaps, less expensive) methods of enforcement and allocating resources to achieve other objectives on its agenda, than the assessment should focus on the decision not to allocate significant resources to compliance reviews.

And, if this latter statement is true, that CMS chose not to allocate significant resources to compliance reviews during the period in question, to analyze this decision, one should look at the opportunity cost of compliance reviews, i.e., the CMS projects that could have been given less attention in order to direct more resources to compliance reviews.

CMS’s response to the report is marked by its disagreement with OIG’s conclusions on the complaint-driven enforcement process. Is CMS saying, with the hand we are dealt, we believe our complaint-driven enforcement model is appropriate?

In reviewing performance, the reviewer should consider the resources available to the performer. Allocation of Federal government resources, already a topic of mainstream discussion, will continue to be dissected heavily in upcoming years given the capital that has been infused into the economy and the likelihood for increased dedication of resources to regulation of the financial industries. Of course, how this resource allocation will affect enforcement in the health care industry remains to be determined.

CMS Issues Advisory Opinion on Stark Rural Provider Exception

CMS issued an advisory opinion concluding, based on the facts certified, that physician owners of a diagnostic center located in a micropolitan statistical area may refer patients to the center for designated health services (DHS) without violating the Federal physician self-referral (Stark) regulations because the arrangement would satisfy the "rural provider" exception.  The rural provider exception, which applies only to ownership or investment interests in DHS entities, requires that (a) the DHS is furnished in a rural area; and (b) substantially all of the DHS furnished by the entity (not less than 75%) must be furnished to residents of a rural area.  "Rural area" means an area that is not an urban area.  "Urban area" is defined at 42 C.F.R. 412.62(f)(1)(ii) to include Metropolitan Statistical Areas and New England County Metropolitan Areas (as defined by the Office of Management Budget) or certain specified New England counties.